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Abstract: Bone healing is a different and unique process that results in complete bone tissue, rather than ending in scar formation.
However, more significant bone defects may fail to regenerate and forms scary granulomatous tissue. This study aimed to investigate
the efficacy of transforming growth factor-β (TGF - β) via platelet rich plasma (PRP) in rabbit tibia bones with segmental bone defects
by radiological and immunohistological methods. Tibial segmental defects were performed to adult New Zealand rabbits (n = 10)
on both legs. 0.5 mL of PRP was administered to the defect zone on one leg (PRP group), while the other leg was closed without
PRP administration (control group). Following six weeks of observation samples were sent for immunohistological examination.
According to Allen’s fracture healing score, the mean score was higher in the PRP group compared to the control group (3.2 vs. 1.3).
Immunohistological evaluations revealed that in the control group, samples were mostly at the early stages of bone development,
whereas in the PRP group, later stages of development were able to be observed (P < 0.05). PRP administration increases bone union,
reduces healing time, and it may provide a more cost-effective treatment with fewer complications in segmental bone defects.
Key words: Platelet-rich plasma, transforming growth factor, segmental bone defect, rabbit, tibia

1. Introduction
Bone healing is a different and unique process that
results in complete bone tissue, rather than ending in
scar formation. However, more significant bone defects
may fail to regenerate thoroughly and terminate in
regeneration that forms scary granulomatous tissue,
especially for reasons such as traumas, tumors, infections,
congenital anomalies, which may negatively affect
peripheral healing structures. It is for sure that autologous
bone grafting is the gold standard in reconstructing
these defects. Nevertheless, additional incision necessity,
donor site morbidity, complications during harvesting
autologous bone may put surgeons in trouble [1]. Besides,
the formation of new bone is a long process and brings
complication risks such as surgical infections, joint
stiffness, soft tissue contractures. In order to reduce the
risk of these complications, the treatment period should be
shortened by accelerating bone formation. Regenerative
medicine helps to overcome these shortcomings [2],
but due to potential risks of infection, allergic reactions,
and transmission of pathogens, the administration of
heterologous materials may not be preferred.

Platelet-rich plasma (PRP) is a plateletpheresis-derived
autologous concentration of platelets in a small volume of
plasma that includes many growth factors [3,4], which
have been shown to have therapeutic effects on fracture
healing [5,6,7]. PRP acts as fibrin gel (bio-glue), provides
homeostasis during and after surgery, and acts as a tissue
adhesive [8]. Since it is autologous, it is not allergic, and
there is no risk of rejection. It accelerates the wound
healing process with the secretory growth factors in its
content [9]. Additionally, the small amount of leukocytes
and the antibody proteolytic enzymes inside its content,
makes it act as a physiological antibiotic in addition
to its osteoinductive activity [10]. Its plasma contains
hormones, biotransformed vitamins, and other nutrients
[11]. Because of these features, PRP is widely used in
clinical applications of bone, tendon, ligament, cartilage
tissue injuries, and osteoarthritis [12].
The cytoplasmic granules of platelets contain several
growth factors such as transforming growth factors (TGF
- β1, TGF - β2, TGF - β3), platelet-derived growth factors
(PDGF αα, PDGF ββ, and PDGF αβ), vascular endothelial
growth factor (VEGF), and epithelial growth factor (EGF)
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[7,13,14]. PRP helps neo-collagenous tissue formation
with its TGFs, neo-vascularization with EGF and VEGF,
and extracellular matrix formation with PDGF [15,16].
In particular, TGF-β1, TGF-β3, growth/differentiation
factor 5 (GDF5), bone morphogenetic proteins (BMP-2
and BMP-7) are factors that stimulate hyaline cartilage
and fibrous cartilage development [17]. These factors
cause chondrocyte hypertrophy, collagen type X, alkaline
phosphatase, and osteocalcin expression [17]. Especially
TGF and BMP-2 are the growth factors that provide
chondrogenic differentiation [18]. Additionally, deposition
of the matrix in the cartilage tissue, chondrogenic
differentiation, and reduction of the inhibitory effect of
interleukin-1 (IL-1), which inhibits proteoglycan synthesis
are among the essential functions of PRP [19,20].
TGF-β is a growth factor that regulates many biological
activities, such as cell reproduction, differentiation,
adhesion, migration, and apoptosis [21]. It stimulates the
proliferation of fibroblasts and mesenchymal stem cells
(MSCs) [22]. In addition to platelets, TGF-β is stored
in the bone as well, since it is produced by osteoblasts,
chondroblasts, and macrophages in the bone. It is highly
synthesized during endochondral ossification and
regulates chondrogenesis by differentiating osteogenic
and chondrogenic MSCs [23]. During bone healing,
TGF-β1 regulates osteoblast mitosis, while TGF-β2 and
β3 regulate chondrogenesis. TGF-β2 is highly secreted
in proliferation, hypertrophy, and mineralization phases
[24]. In the first stages of osteogenesis, TGF allows the
stem cells to differentiate into osteoblasts, but due to
the increase of bone cell resources in the late period,
osteoblast formation, mineralization, and differentiation
are inhibited [25]. BMPs belong to the TGF-β family,
and they enable the stem cells to be transformed into
chondroblasts for enchondral ossification, and into the
osteoblastic stem cells for membranous ossification [26].
Committed osteoblastic stem cells form pre-osteoblast
I and II, and these cells, with the help of BMP, insulinlike growth factor (IGF), and TGFs, are transformed into
osteoblasts, and membranous ossification occurs [27].
Within the elucidation of all these data, this study
aimed to investigate the efficacy of PRP, particularly the
role of TGF in rabbit tibia bones with segmental bone
defects, by immunohistological methods.
2. Materials and Methods
This study was initiated after obtaining approval from the
local Ethics Committee for Animal Research (approval
no./date: B30CAU00506-050.04-122/04 December 2014).
Principles of “laboratory animal care” (NIH publication
No. 86-23, revised 1985) were followed. Male and female
(n = 5 for each sex), adult (1 year of age), New Zealand
rabbits (n = 10), with bodyweights ranging approximately
between 2000–2500 g, were obtained and identified with
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numbers. Rabbits were housed in individual cages with
free access to ad libitum food and water. On the day of
surgery, anesthesia was applied intramuscularly with 3 mg/
kg xylazine (Bayer Corporation, Whippany, New Jersey,
USA) and 35 mg/kg ketamine hydrochloride (Pfizer Inc.,
Parke Davis, New York, USA). Following the anesthesia,
both tibias were shaved, disinfected, and the skin incisions
were made over the medial aspect of the tibias in the sterile
surgery room. Tibial diaphyses were exposed following
the separation of muscles and stripping periosteum.
Osteotomies were performed using an electric micro-saw,
immediately distal to the tibiofibular synostosis line. A 4
mm bony block was removed to form a segmental defect
in a standard manner. The defect was stabilized using a
mono-lateral external fixator and four K-wires instead of
internal plate fixation to avoid surrounding tissue harm
bias. Unlike the human tibia, the rabbit tibia may be
subjected to nonaxial shear forces during gait. Therefore,
casts were applied over the fixators above the knee level
using cotton pads and gypsum.
In the meantime, 8 mL of peripheral venous blood
was collected from the auricular vein of each rabbit and
separated using a standard PRP kit to obtain autologous
PRP. Before closing the wound in layers, 0.5 mL of PRP
was administered to the segmental defect on one leg (PRP
group), while the wound on the other leg was closed
without PRP administration (control group). In the PRP
group, PRP was administered to half of the rabbits in
the right leg and the other half in the left leg in order to
eliminate the extremity side bias. The remaining portion of
the PRP sample was sent to the laboratory to confirm that
the platelet count is over 1 million/mL [28,29,30].
While rabbits were still anesthetized, intra-operative
x-ray images were taken to confirm the placement of
fixators, defect, and alignments. For each rabbit, the
rabbit ID and the PRP administered side were recorded.
Antibiotic prophylaxis of cefazolin sodium (25 mg/
kg intramuscular) was initiated (GlaxoSmithKline
plc., Wales, UK) and continued for three days with
three administrations each day. Postoperative pain was
managed by subcutaneous injection of 4 mg/kg carprofen
(Zoetis Services Llc, Parsippany, NJ, USA) twice daily for
seven days. For each rabbit, weekly x-ray examinations
were conducted to check callus development (Figure 1).
Skin sutures were removed two weeks after the surgery.
Following six weeks of observation, rabbits were sacrificed
by 100 mg/kg intravenous injection of sodium thiopenthal
(Abbott Laboratories, Illinois, USA), and tibias were
removed and sent for histological examination.
Bony tissue samples taken for histological examinations
were fixed in 10 % neutral buffered formalin for 72 hours.
For decalcification of bone tissue samples, solutions of
formic acid (125 mL of 90 % formic acid + 125 mL distilled
water) and sodium citrate (50 g of sodium citrate + 250
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Figure 1. Peroperative and follow-up x-ray images.

mL of distilled water) were prepared and mixed in equal
volume. Bone samples were kept in a mixture of formic
acid sodium citrate solution for one week. The solution was
changed daily to improve decalcification. The decalcified
tissues were washed in running tap water for 24 h, passed
through alcohol, cleared with xylene, and embedded in
paraffin longitudinally. Five sections of 6 microns were
taken from each tissue sample. Hematoxylin and eosin
staining was used for examining the histological structure
of the bone tissue, whereas Safranin O-Fast Green staining
was preferred to investigate hyaline cartilage and collagen
structure in the area of calcification.
Moreover, TGF-β containing cells in tissue samples
were immunohistochemically stained with the
streptavidin-biotin method. Inflammation, angiogenesis,
fibrous tissue, collagen fiber, safranin O-positive cartilage
tissue, chondrocyte hypertrophy, and newly formed bone
tissue density were evaluated in terms of histological
changes, and scoring was performed. Image analysis was
performed using a personal computer, a camera, software
(Olympus SC30), and high-powered light microscopy
(CX-41, Olympus). A seven-point semiquantitative
scoring system (modified Allen’s grading) [31,32] was
used for the evaluation of fracture healing. The adopted
scoring system is presented in Table 1.
All data were presented as mean. Non-parametric
analyses (Kruskal–Wallis and Mann–Whitney tests)
were used due to the small sample size to compare the

differences between control and PRP groups. P-values less
than 0.05 were considered significant.
3. Results
During the follow-up period, one rabbit died on day 8,
another rabbit died on day 16, and both were excluded
from the study. The results of the remaining eight rabbits
(totally 8 specimens for control group, and 8 specimens
for PRP group) were presented in this paper. In the
tibial defected zone of the rabbits, histological findings
of different intensities were obtained between PRP and
control groups. The mean grade score was higher in the
PRP group compared to the control group, according to
Allen’s fracture healing score (3.2 vs. 1.3) (P < 0.05). In
both groups, an increased number of fibroblasts in the
callus area, fibrocartilaginous tissue, hyaline cartilage
proliferation, and soft and hard callus area formation
characterized by hypertrophic chondrocytes were
observed (Figure 2– 5). Besides, many newly formed
small blood vessels and proliferated cells around these
vessels were also observed (Figure 4). The rabbits in the
PRP group were generally in grades 3 and 4, according to
Allen’s grading (Table 2).
In the defected zone of the control group, vascular
fragmentation and scattered bone marrow were observed,
but rare appearance of inflammatory cells, increase of
intense fibrous tissue, vascular invasions, and very little
hyaline cartilage proliferation indicated newly developing
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Table 1. Allen’s fracture healing scoring.
Healing

Score

Nonunion (fibrous tissues)

0

Incomplete cartilage union (cartilage with some fibrous tissues)

1

Complete cartilage union (entirely cartilage)

2

Incomplete bony union with phase of ossification (predominantly cartilage with some trabecular bone)

3

Incomplete bony union with intermediate phase of ossification (equal amounts of cartilage and trabecular bone)

4

Incomplete bony union with late phase of ossification (predominantly trabecular bone with some cartilage)

5

Complete bony union (entirely bone)

6

Figure 2. Micrograph of grade 1 in the control group. It displays
the formation of severe vascular invasion and proliferative fibrous
tissue, hyaline cartilage tissue. V: vascular invasions, C: hyaline
cartilage, PF: proximal fracture of tibia, DF: distal fracture of the
tibia. H&E staining.

callus formation (Figure 2). Most of the specimens in the
control group were found to have fibroblasts that form a
soft callus, chondrocyte-like cells, and some safraninpositive proliferative hyaline cartilage tissue (Figure 3).
According to these findings, it was concluded that the
callus areas were generally grades 0 and 2 in the control
group (Table 2).
In the PRP group, hypertrophic chondrocytes
indicating the terminal ossification stage were abundant.
Lamellar bone tissue was observed in the hard callus
areas of the fracture ends, which was a sign of the
remodeling process (Figure 4,5). In the PRP group, a more
considerable amount of hard callus (woven bone) and a
small amount of soft callus containing fibrocartilaginous
tissue showed that endochondral ossification had started
earlier than the control group. Although the trabecular
bone was developed by endochondral ossification in the
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Figure 3. Micrograph of grade 1 in the control group. It shows the
formation of safranin O positive hyaline cartilage and network
of immature bone (woven bone) associated with endochondral
ossification. SO +: safranin O positive hyaline cartilage, FCT:
proliferative fibro-cartilaginous tissue, HC: hypertrophied
chondrocytes, PC: proliferative chondrocytes, WB : remodeling
woven bone. Fast green safranin O staining.

PRP group, it was determined that the callus zone did
not consist entirely of mature bone cells, instead, the
gap between fracture ends was mostly filled with hyaline
cartilage model (Figure 5). At the ends of the lamellar
bones, a minimal amount of fibrocartilaginous tissue
with membranous ossification was observed, whereas,
in the trabecular bones, callus formation began with an
endochondral ossification (Figure 4, 5).
Safranin-O staining showed an intensive positivity
in the areas with soft callus, and in the areas of cartilage
matrix with mineralized hard callus, Safranin-O staining
showed partial positivity. It was concluded that these areas
consisted of hypertrophic chondrocytes and partially
cartilage tissue matrix (Figure 5). In the control group,
findings such as an abundant increase in fibrous tissue
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Figure 4. Micrograph of grade 3 in the PRP treated rabbit.
It displays the formation of vascular invasion, stem cells,
proliferative and hypertrophied chondrocytes, and network of
immature bone (woven bone) associated with endochondral
ossification. V: vascular invasions, SC: stem cells, HC:
hypertrophied chondrocytes, PC: proliferative chondrocytes,
WB: remodeling woven bone. Hematoxylin and Eosin staining.

and the formation of angiogenesis in addition to the
presence of a small amount of hyaline cartilage tissue were
considered as an indicator of the slow development of the
endochondral ossification process.
Above all, in immunohistochemical staining,
proliferative chondroblasts and fibroblast-like cells in
the callus area were stained TGF-β immunopositive
with the streptavidin-biotin method. On the other hand,
hypertrophic chondrocytes were immunonegative. In the
woven bone tissue chondroblasts, osteoblasts, osteoid
tissue, and in the mature bone tissue, most of the osteocytes
were immunopositive (Figure 6 A–6D). In addition, the
stem cells, matrix, fibroblasts, and chondroblasts in the
areas, in which angiogenesis formated, were intensively

Figure 5. Micrograph of grade 4 in the PRP treated rabbit. It shows
the formation of hyaline cartilage and network of immature bone
(woven bone) associated with endochondral ossification. SO +
HC: safranin O positive hyaline chondrocytes, WB: remodeling
woven bone. Fast green safranin O staining.

detected and stained TGF-β immunopositive (Figure 6A).
The proliferative chondroblasts, vascular invasion, and
presence of hard callus areas were more pronounced in the
PRP group comparing to the control group, which resulted
in an increased TGF-β immune positive matrix and cell
density. Other histological properties were similar in both
groups in terms of immunopositivity.
According to Allen’s fracture healing grading, a
higher mean grade score was observed in the PRP group
comparing to the control group, suggesting faster healing
with the administration of PRP (P < 0,05).
4. Discussion
Formation of new bone is a long process and brings
complication risks, which can be reduced by shortening
the treatment period. Several methods, including

Table 2. Mean fracture healing scores in rabbit tibia after distraction.
Allen’s fracture healing score

Control group
(n = 4)

PRP group
(n = 4)

Fibrous tissues

3

0

Cartilage with some fibrous tissues

4

1

Entirely cartilage

2

3

Predominantly cartilage with some trabecular bone

0

4

Equal amounts of cartilage and trabecular bone

0

3

Predominantly trabecular bone with some cartilage

0

0

Entirely bone

0

0

PRP: Platelet rich plasma
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Figure 6. Transforming growth factor-beta immunopositive cells in the PRP treated rabbit. It shows positive cells in the callus zone. iHC:
immunonegative hypertrophic chondrocytes, iPC: immunopositive proliferative chondrocytes, oWB: osteoblast-like immunopositive
cells in woven bone, V: vascular invasion, arrows: immunopositive stem cells in the vascular invasion areas, bold arrows: immunopositive
osteocytes, curved arrows: immunonegative osteocytes. Streptavidin biotin peroxidase staining.

intramedullary nailing, low-intensity ultrasound,
recombinant growth hormone, were proposed in order to
reduce treatment time. PRP is developed from autologous
blood, and there are published studies about fracture
healing [5,6,7]. However, there are also controversial
results in the literature regarding the effect of PRP on bone
regeneration [33,34].
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Among all these studies, TGF-β and PRP effects on
segmental bone defects were rarely analyzed. In our
study, histological findings were in different intensities
between control and PRP groups. We saw endochondral
ossification primarily occurred in the trabecular bone
areas of defected tibias and intramembranous bone
tissue formation in the lamellar bone regions. Besides,
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hypertrophic chondrocytes, together with the Safranin-O
positive matrix, were observed in the calcified newly
formed hard callus areas. These data made us think about
the possible effect of TGF-β in PRP. So, in this study,
we aimed to investigate the effect of TGF-β via PRP in
segmental bone defects of rabbit tibia.
TGF-β stimulates differentiation of the cell types
involved in the healing process [35]. While TGF-β increases
mitosis in the bones during fracture healing, it also supports
the formation of hyaline cartilage. The presence of TGF-β
immunopositive angiogenetic cells and chondroblast
density in rabbit tibias treated with PRP may indicate that
PRP has a positive effect on cartilage tissue neogenesis
via TGF-β. Besides, systemic and local administration of
TGF-β1 has been shown to enhance bone remodeling and
fracture healing in animal models [36,37].
Marx et al. reported that the administration of PRP to
grafts might accelerate bone maturation rate 1.6 to 2.1 times
compared to grafts without PRP [38]. They mentioned
that fundamental growth factors such as PDGF and
TGF-β enhance the rate of bone formation and increase
the amount of bone formed. The role of growth factors
such as TGF-β, IGF-1, and basic fibroblast growth factor
(bFGF), has been investigated in many studies [39,40,41].
Farhadieh et al. studied the roles of growth factors such
as TGF-β, IGF-1, bFGF, and reported that the presence of
growth factors (IGF-1 and bFGF) in the union region with
high concentration might lead to osteoblast proliferation
and formation from precursor mesenchymal cells [39].
Zimmermann et al. prospectively assessed systemic
changes in TGF-β levels of patients with delayed healing
and nonunion of long bone fractures [42]. He found that
in both normal and nonhealing groups, the serum level of
TGF-β1 increased within the first two weeks after fracture,
but the delayed healing group had a faster decline of serum
concentration between 2 and 4 weeks after the trauma and
its level was significantly lower in the delayed fracturehealing group at four weeks. Systemic levels of TGF-β were
found to vary based on smoking status, age, sex, diabetes
mellitus, and chronic alcohol abuse at different time points
[43]. Moreover, Sarahrudi found no significant differences
in the TGF-β1 concentrations of delayed and normal
fracture healing groups [44]. So, an immunohistological
investigation was performed in our study to eliminate such
conditions.

Does exogenous TGF-β work on the fracture site? Lind
et al. applied 10 µg/day TGF-β to rabbit tibias for six weeks
and found increased maximal bending strength and callus
formation, but they reported no effect on bending-stiffness,
bone mineral content, cortical thickness or Haversian canal
diameter [45]. Again, immunohistological investigations
were needed to reveal more definite conclusions.
Srouji et al. investigated bone regeneration induced
by TGF-β and IGF-1-containing hydrogel scaffolds in
rat tibia defect models [46]. They found that scaffolds
containing TGF-β could function both osteoinductive and
osteoconductive as a matrix for TGF-β, and a site for bone
osteointegration. Nevertheless, exogenous TGF may be
hard to provide, so PRP seems to be the most affordable
way of the belief “treat the person with the person himself ”.
In a similar animal study model, Kanthan et al.
reported good outcomes with PRP in larger bone defects
[47]. They reported enhancements in the repair of delayed
bone unions involving critical-sized defects with PRP. They
concluded that a bone-replacement material was needed
for PRP to be efficient in a 2 cm - defect model of rabbit
tibiae. However, their defect was five times larger than our
model. Thus, further studies may reveal how large defect
size needs graft with PRP.
Despite promising results, this present study has several
limitations: the number of subjects would be higher, biped
animals would be chosen instead of quadruped animals
to mimic human behavior more, and biomechanical tests
would be applied. These may all be inspirations for future
works.
5. Conclusion
In this study, the effectiveness of TGF-β via PRP on
segmental bone defect healing was investigated. PRP
administration increases bone union, reduces the healing
time, and with these advantages, it may provide a more
cost-effective treatment with fewer complications in the
treatment of segmental bone defects.
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